| abstract |
Formula I, which is an antagonist of the CGRP receptor and is useful in the treatment or prevention of diseases involving CGRP (eg, migraine): (Wherein variables A 1 , A 2 , B, m, n, J, R 4 , G 1 , G 2 , G 3 and Y are as defined herein). A compound having The invention also relates to pharmaceutical compositions comprising said compounds and to the use of said compounds and compositions in the prevention or treatment of said diseases in which CGRP is involved. |